Abstract
Enteroviruses (EVs), especially coxsackieviruses B (CVB), are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals that results in type 1 diabetes (T1D). Therefore, strategies are needed to fight against EV infections. There are no approved antiviral drugs currently available, but various antiviral drugs targeting viral or host cell proteins and vaccines have recently shown potential to combat CVB infections and may be used as new therapeutic strategies to prevent or reduce the risk of T1D and/or preserve β-cell function among patients with islet autoantibodies or T1D.
Funder
Ministère de l’Education Nationale de la Recherche et de la Technologie, Université de Lille
Subject
Virology,Microbiology (medical),Microbiology
Reference96 articles.
1. ICTV Virus Taxonomy Profile: Picornaviridae
2. Recommendations for the nomenclature of enteroviruses and rhinoviruses
3. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses;Pallansch,2013
4. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes;Alidjinou;Discov. Med.,2014
5. Acute and chronic disease caused by enteroviruses
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献